Literature DB >> 10817744

Failure of azithromycin in treatment of Brill-Zinsser disease.

D Turcinov1, I Kuzman, B Herendić.   

Abstract

Two patients suffering from Brill-Zinsser disease were treated with azithromycin, which did not prove effective. Rickettsia prowazekii, the agent causing Brill-Zinsser disease, cannot be treated with azithromycin. Both patients had epidemiological features consistent with and a clinical course typical of the disease. The diagnosis of Brill-Zinsser disease was serologically confirmed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10817744      PMCID： PMC89948          DOI： 10.1128/AAC.44.6.1737-1738.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Treatment of louse-borne typhus fever with chloramphenicol, tetracycline or doxycycline.

Authors:  D W Krause; P L Perine; J E McDade; S Awoke
Journal:  East Afr Med J       Date:  1975-08

2.  A clinico-epidemiological study of epidemic typhus in Africa.

Authors:  P L Perine; B P Chandler; D K Krause; P McCardle; S Awoke; E Habte-Gabr; C L Wisseman; J E McDade
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

3.  Treatment of epidemic typhus. A comparative study of chloramphenicol, trimethoprim-sulphamethoxazole and doxycycline.

Authors:  J Huys; P Freyens; J Kayihigi; G Van den Berghe
Journal:  Trans R Soc Trop Med Hyg       Date:  1973       Impact factor: 2.184

4.  Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis.

Authors:  C W Yim; N M Flynn; F T Fitzgerald
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Single-dose doxycycline treatment of louse-borne relapsing fever and epidemic typhus.

Authors:  P L Perine; D W Krause; S Awoke; J E McDade
Journal:  Lancet       Date:  1974-09-28       Impact factor: 79.321

6.  In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected Vero cell monolayers.

Authors:  T J Ives; P Manzewitsch; R L Regnery; J D Butts; M Kebede
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

Review 7.  Azithromycin: the first azalide antibiotic.

Authors:  C H Ballow; G W Amsden
Journal:  Ann Pharmacother       Date:  1992-10       Impact factor: 3.154

8.  In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus.

Authors:  D Strickman; T Sheer; K Salata; J Hershey; G Dasch; D Kelly; R Kuschner
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191
  8 in total
  7 in total

1.  Persisting Rickettsia typhi Causes Fatal Central Nervous System Inflammation.

Authors:  Anke Osterloh; Stefanie Papp; Kristin Moderzynski; Svenja Kuehl; Ulricke Richardt; Bernhard Fleischer
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

2.  Rickettsia-macrophage interactions: host cell responses to Rickettsia akari and Rickettsia typhi.

Authors:  S Radulovic; P W Price; M S Beier; J Gaywee; J A Macaluso; A Azad
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Eradication of typhus exanthematicus in Bosnia and Herzegovina.

Authors:  Zlatko Puvacić; Edina Beslagić; Sukrija Zvizdić; Sandra Puvacić; Jelena Ravlija; Sadeta Hamzić
Journal:  Bosn J Basic Med Sci       Date:  2006-02       Impact factor: 3.363

4.  CD4+ T Cells Are as Protective as CD8+ T Cells against Rickettsia typhi Infection by Activating Macrophage Bactericidal Activity.

Authors:  Kristin Moderzynski; Stefanie Papp; Jessica Rauch; Liza Heine; Svenja Kuehl; Ulricke Richardt; Bernhard Fleischer; Anke Osterloh
Journal:  PLoS Negl Trop Dis       Date:  2016-11-22

Review 5.  Immune response against rickettsiae: lessons from murine infection models.

Authors:  Anke Osterloh
Journal:  Med Microbiol Immunol       Date:  2017-08-02       Impact factor: 3.402

6.  A Prospective, Open-label, Randomized Trial of Doxycycline Versus Azithromycin for the Treatment of Uncomplicated Murine Typhus.

Authors:  Paul N Newton; Valy Keolouangkhot; Sue J Lee; Khamla Choumlivong; Siho Sisouphone; Khamloune Choumlivong; Manivanh Vongsouvath; Mayfong Mayxay; Vilada Chansamouth; Viengmon Davong; Koukeo Phommasone; Joy Sirisouk; Stuart D Blacksell; Pruksa Nawtaisong; Catrin E Moore; Josée Castonguay-Vanier; Sabine Dittrich; Sayaphet Rattanavong; Ko Chang; Chirapha Darasavath; Oudayvone Rattanavong; Daniel H Paris; Rattanaphone Phetsouvanh
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079

Review 7.  The neglected challenge: Vaccination against rickettsiae.

Authors:  Anke Osterloh
Journal:  PLoS Negl Trop Dis       Date:  2020-10-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.